Michael Thick Joins IMS MAXIMS

IMS MAXIMSRenowned health informatics leader Michael Thick has this week been appointed as chief medical officer (CMO) and chief clinical information officer (CCIO) of electronic patient record software pioneer IMS MAXIMS.

Well known for his position as chief clinical officer on the National Programme for Information Technology, he has been instrumental across various successful clinical, informatics and research initiatives, including the introduction of the 'clinical five' into the Department of Health's 2008 health informatics review - a basis for fundamental clinical functionality within a hospital today.

The former surgeon and clinical informatics lead at the Department of Health will lead the company's continued focus on clinical excellence and apply his valuable insight and experience into software design, product development and change programmes for healthcare providers.

"I will offer a deeper understanding of the NHS, specifically around clinical processes for IMS MAXIMS’ customers, whilst supporting the development of clinical governance within the product portfolio to ensure they are safe and effective," said Thick.

Commenting on his appointment by IMS MAXIMS, Thick said: “It is a highly ambitious company driving innovation and change that is developing its strong reputation within the health service.

"I was attracted by the company’s clear understanding of the way healthcare needs to develop and its deep knowledge of business transformation to support sustainable new models of clinical care. It is an agile organisation that is able to change and adapt quickly where necessary to produce the correct tools for clinicians to deliver safer care."

On the role of electronic patient record (EPR) technology in the NHS, Thick said: "EPRs are essential to clinical practice. If we are going to achieve improvements in the quality of healthcare in terms of outcomes and patient experience, and redesign the NHS to become more clinically-based, then the only piece of technology that will be able to support those needs is an electronic patient record."

For IMS MAXIMS, the appointment of Thick represents a long-term commitment to develop and innovate healthcare software systems and applications that enhance patient safety and outcomes and support the delivery of best practice.

The company has been pioneering in the use of open source software after releasing the software code to become the first open source electronic patient record provider in the UK.

Its openMAXIMS solution is currently being deployed at Taunton and Somerset NHS Foundation Trust, which is due to become the first acute NHS trust to implement an open source EPR later this year. In January it was announced that UK private hospital provider, Ramsay Healthcare, was partnering with IMS MAXIMS for 10 years after signing an agreement to use its open source EPR and clinical modules to improve patient satisfaction and outcomes.

"Clinical safety should be at the heart of any healthcare software," said Shane Tickell, chief executive of IMS MAXIMS. "We've held that as our company ethos since the beginning and have continued to innovate and develop our solutions alongside clinicians over nearly 30 years. We welcome Michael to our growing team of talented individuals as we continue to recruit quality personnel committed to improving patient outcomes."

Thick's 30-plus years' clinical and informatics experience has been built over a decorated career in the public sector. During his time at the Department of Health, he also served as senior medical advisor to the Choose and Book and PACS (picture archiving and communication system) programmes. The former consultant transplant surgeon has developed many clinically-led systems, including working with the end of life team at The Royal Marsden NHS Foundation Trust to co-design Coordinate My Care, a shared end of life care register.

His achievements at a national level have been preceded by an established career within clinical practice. After qualifying as a doctor in 1976 from Cambridge University, he went on to become director of liver and renal transplantation at the Freeman Hospital in Newcastle, and served as chairman of the IM&T Strategy Committee for the city’s hospitals.

Until recently a professor of genomics at Imperial College London, Thick spent ten years researching the use of genomics and data mining big phenotypic datasets, techniques which will require EPRs to deliver personalised medicine. Other achievements include being appointed senior registrar to Professor Sir Roy Calne in Cambridge, and setting up several transplant units across the NHS. He is currently a member of the Digital Health Chief Clinical Information Officer (CCIO) Leaders Network.

About IMS MAXIMS
IMS MAXIMS is an open source and proprietary electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations and 11 million patient records in the UK. In Ireland, there are 20,000 users of IMS MAXIMS products, where it supports 1.9 million patient records, representing around 50% of the population.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...